Water molecules chemically bound within lactose monohydrate crystal structure, essential for pharmaceutical stability and performance.
| Parameter | Typical range | Notes & selection driver |
|---|---|---|
| Bulk Density | 0.5-0.7 g/mL | |
| Crystal Form | α-lactose monohydrate | |
| Water Content | 4.5-5.5% w/w (Karl Fischer) | |
| Loss On Drying | <0.5% | |
| Specific Surface Area | 0.3-0.8 m²/g | |
| Particle Size Distribution | D50: 50-150 μm |
Ranges are indicative industry figures for RFQ preparation, not a supplier commitment. Confirm every value and standard with the legal manufacturer before ordering.
This component is used in the following industrial products
A practical evidence checklist for RFQ preparation and supplier evaluation.
Compare the published product scope and source details, then include your specifications and quantity in an enquiry.
Manufacturer profiles associated with Bound Water Molecules.
Explore company information and manufacturing capabilities, then discuss the scope of your project with a relevant supplier.
Bound water molecules maintain the α-lactose monohydrate crystalline structure, which provides consistent compaction properties, predictable dissolution behavior, and protection against moisture-induced degradation of active pharmaceutical ingredients.
Bound water cannot be removed without converting lactose to anhydrous form, which alters its pharmaceutical properties. Complete dehydration requires heating above 130°C and changes the material's compaction and dissolution characteristics.
Bound water acts as an internal lubricant during compression, improves powder flowability, and contributes to tablet hardness through solid bridge formation during drying cycles in fluid bed processors or tray dryers.
Editorial classification, named public sources where available, and source-reviewed manufacturer records. See the editorial policy.